Health Sciences Acquisitions Corp (44) | License Agreements (2)
- License Agreement, dated December 19, 2017, by and between Roivant Sciences GmbH and HanAll BioPharma Co., Ltd (Filed With SEC on December 20, 2019)
- Assignment and Assumption Agreement, dated as of December 7, 2018, by and between Immunovant Sciences GmbH and Roivant Sciences GmbH, relating to the License Agreement by and... (Filed With SEC on December 20, 2019)
